New tools for diagnostic of HCC remain to further investigate. We have evaluated the expression of SCCA1, 2 mRNA and their prognostic value in hepatocellular carcinoma (HCC).Reverse transcription polymerase chain reaction (RT-PCR) and direct sequencing were performed to evaluate the mRNA expression of SCCA1 and SCCA2 in 93 HCCs, and 93 paired adjacent non-cancerous tissues (PNT), 16 cirrhosis livers and 9 normal livers. The correlation of SCCA variants expression with the clinical parameters and the factors affecting survival were analyzed statistically.Total SCCA was detected in 33.3% of HCCs (31/93), in 9.68% of PNT (9/93) and 22.2% of normal livers (2/9). No expression was found in cirrhosis livers (0/16). The frequencies of total SCCA expression were significantly higher in HCCs than that in PNT and liver cirrhosis (p = 0.000, 0.006). From mRNA sequencing of HCCs, a new SCCA1 variant (presenting a T357A mutation) was identified in 16 specimens, while wild type SCCA1 was identified in 11 specimens and SCCA2 in 27 specimens. Clinicopathological analysis showed that the frequency of SCCA1 was significantly higher in poorly differentiated HCC, compared with moderately and well differentiated tumors (p = 0.021). T357A variant has a significantly higher frequency in nonencapsulated tumors than wild type SCCA1 (p = 0.034).The SCCA1, 2 mRNA is effective for detecting HCC and could be potentially applied in HCC diagnosis. Key words: hepatocellular carcinoma, liver diseases, prognosis, squamous cell carcinoma antigenNeoplasma 61, 6, 2014 doi:10.4149/neo_2014_087 Liver cancer is the fifth most frequently diagnosed cancer but the second most frequent cause of cancer death in men worldwide (half of these cases and deaths are estimated to occur in China), and approximately, 70-85% of the total liver cancer are classified as hepatocellular carcinoma (HCC) [1]. Early detection enables us to provide the patients with more therapeutic options, which can improve survival rate of patients and reduce medical costs [2]. Despite the fact that serum AFP is still the golden standard amongst diagnostic markers for HCC, its diagnostic value is more and more questioned, because of its poor sensitivity and specificity [3,4]. Therefore, investigators are seeking for better HCC biomarkers.Squamous cell carcinoma antigen (SCCA), originally isolated from SCC tissue of the uterine cervix, is a member of the family of serine protease inhibitors [5]. The neutral and acidic isoforms of SCCA are encoded by 2 separate, but highly homologous genes, SCCA1 and SCCA2, at chromosome 18q21.3 [6]. Although SCCA1 and SCCA2 are with 91% identity at the amino acid concentration, they have distinct properties and substrate specificities. SCCA1 also known as SERPINB3, a papain-like cysteine proteinase inhibitor, inhibits cathepsins K, L and S [7]. SCCA2 also known as SERPINB4, a chymotrypsin-like serine proteinase inhibitor, inhibits proteolytic activity of endogenous cathepsin G and mast cell chymase [8]. The biological role of this serpin in carcinoge...
Drought is a major abiotic factor limiting agricultural crop production. The focus of this study was the effect of triadimefon (TDM) on rapeseed photosynthesis and carbohydrate metabolism in response to drought stress. Results showed that TDM increased plant dry mass per plant and reduced the damage to photosynthetic processes by regulating stomatal and nonstomatal factors, inducing photosynthetic pigment synthesis, and improving photosynthetic activity. Chloroplast degradation and senescence was reduced in rapeseed leaves with TDM under drought stress. TDM restored structural connections between chloroplasts and cell membranes and modified the chloroplasts-from slightly elongated ellipses to archetypical ellipses. TDM also regulated enzymatic activity of sugar metabolism. These results indicate that TDM improved drought tolerance through the regulation of photosynthesis and carbohydrate metabolic pathways in rapeseed at the bolting stage, thereby increasing biomass under drought stress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.